Targeting TNF-α for COVID-19: Recent Advanced and Controversies
Public Health
[키워드] ACE2
acute lung injury
angiotensin-converting enzyme 2
association
characterized
coronavirus disease
COVID-19
CRS
Cytokine release syndrome
Disease progression
effective
facilitate
IL-10
IL-2
IL-7
Infection
infliximab
inhibitors
Interaction
MIS-C
Necrosis
pathophysiologic
pathway
pro-inflammatory cytokine
recent
SARS-CoV-2
severe COVID-19 patients
severe SARS-CoV-2
Severity of disease
targeting
therapeutic strategy
TNF-α inhibitor
TNF-α
Treatment
Trigger
upregulated
[DOI] 10.3389/fpubh.2022.833967 PMC 바로가기 [Article Type] Public Health
[DOI] 10.3389/fpubh.2022.833967 PMC 바로가기 [Article Type] Public Health